Clinical Trial Update: Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing radical surgical resection with ablative stereotactic radiotherapy for operable stage I non-small cell lung cancer has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-01-06